Inventor · disambiguated record
Markus Dangl
Also filed as: DANGL MARKUS
1 granted patent·1 pending application·1 citations·filing 2014–2016
16Inventor score
Files withHOFFMANN LA ROCHE2
Top patents by PatentIndex Score
2 records- 0174US9657351B2MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonistHOFFMANN LA ROCHE·Filed 2014·Granted May 23, 2017·1 cites·16 claims
- 0232US2016347852A1Combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor and a MDM2 inhibitorHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Dangl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →